skip to content

Department of Chemical Engineering and Biotechnology

 

The success of the Department’s spinout companies is tangible; the following companies are representative of those founded by our staff:

EnVal Ltd won the materials/chemistry European ACES Award (2011), the National Recycling Award (2011) and the Finance for the Future Award (2013).

ProMetic BioSciences Ltd/Inc is a publicly listed company on the Toronto Stock Exchange active in the area of oral therapeutics and protein technologies and with a current market capitalisation of $CDN 500M.

Psynova Neurotech Ltd has featured in Business Week and has won the Medical Futures Innovation Award for a business in the Neuroscience sector and more recently, was nominated as the best bioscience spin-out company in Europe (2011), prior to being acquired by Myriad Genetics Inc.  

Smart Holograms Ltd was nominated the fastest growing company in the UK in 2006 and has featured in numerous trade magazines, daily newspapers and the Sunday Times Magazine. It achieved third position in the Telegraph top 50 University spinouts.

Clinical Translation

Research under the Healthcare Biotechnology theme has led to a number of entrepreneurial therapeutic and diagnostic interventions in clinical medicine. Psynova Neurotech Ltd was the first company in the world to introduce a biochemical test for schizophrenia and is currently investigating a range of biomarkers for a generic ‘neuropsychiatric disorder’ test to distinguish all major types of mental disorder. Cambridge Sensors Ltd has transformed from a blood glucose test company into a medical device company with a focus on diabetes and now sells insulin pen needles, hypoglycaemia gels, lancets and disinfection products in addition to Microdot® blood glucose systems.    ProMetic BioSciences is developing therapeutics to treat blood-related disorders and is a world-leading technology provider and drug developer in the fields of haematology, oncology and nephrology.

Graduate Student Commercial Activities

Students from the MBE and other courses participate in local, national and international business plan competitions and have established a number of spin-out companies over the 12 or so years the course has run. Successful consultancy companies include Costello Medical Consulting which provides specialised market access and medical communication services to the pharmaceutical industry and now employs 45 people in Cambridge and Hybridigm Consulting in Malaysia. CamStent, a medical materials company based in Cambridge, has completed several rounds of funding. More recently, Desktop Genetics Ltd, a bioinformatics company founded by three graduates of the MBE course has recently raised £375,000 in venture funding together with a £100,000 Technology Strategy Board grant.

Latest news

From PhD student to CEO

15 August 2019

Alumnus founds microcapsule start-up for the product industry

July paper of the month: Christie lab discovers two new enzymes responsible for spore germination

9 August 2019

Researchers from our Molecular Microbiology group have identified two new enzymes responsible for breaking open bacterial spores when they germinate.

Dr Marta Serrani through to semi-finals of the Postdoc Business Plan Competition

8 August 2019

Dr Serrani’s start-up, Polivalve, will look to bring the prosthetic heart valves developed by our structured materials research group to the market.